Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil + propofol versus ketamine + propofol for anesthesia during oocyte retrieval for ICSI
IRCT20120110008677N7Phase 3Completed
- Sponsor
- Mehr Medical Institute
- Start
- Nov 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of propofol, ketamine, remifentanil and lidocaine in infertility (2 arms), sponsored by Mehr Medical Institute. Primary endpoints: Fertilization rate and Clinical pregnancy. Started Nov 2021; status: completed.
02
Drugs
propofolketamineremifentanillidocaine
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT20120110008677N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120110008677N7.